ESR2 and triple-negative breast carcinoma: Geographic incidences of ER negative breast cancer are highly variable both within the U.S. and internationally79–81, and this disparity has been associated with higher incidences of ERα negative, ERβ positive, and triple-negative breast cancer in women of African descent82–84.